Journal of Addiction Research & Therapy
Open Access

Kenneth Blum

Department of Psychiatry, McKnight, Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA

Biography

Department of Psychiatry & Mcknight Brain Institute, University of Florida College of Medicine, Gainesville FL, USA, Human Integrated Services Unit University of Vermont, Center for Clinical & Translational Science, College of Medicine, Burllington, VT, USA, Department of Nutrigenomics, Bio Clarity, Inc. La Jolla, CA, USA, Impact Genomics, LLC, Lederoch, PA, USA, Department of Clinical Neurology, Path Foundation, NY, New York, USA, Department of Personalized Medicine, IGENE, LLC, Austin, Texas, USA, Dominion Diagnostics, LLC, North Kingstown, Rhode Island, USA

Publications

Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?

There is a plethora of research indicating the successful treatment of opioid dependence with either buprenorphine alone or in combination with naloxone (Suboxone®). However, we encourage caution in long-term maintenance with these drugs, albeit, lack of any other FDA approved opioid maintenance compound to date. Our concern has been supported... Read More»

Kenneth Blum, Marlene Oscar-Berman, William Jacobs, Thomas McLaughlin and Mark S. Gold

Commentary: J Addict Res Ther 2014, 5: 185

DOI: 10.4172/2155-6105.1000185

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article